Nuwellis Other Liab from 2010 to 2024

NUWE Stock  USD 1.17  0.04  3.31%   
Nuwellis' Other Liabilities is increasing over the years with slightly volatile fluctuation. Overall, Other Liabilities is expected to go to about 8.3 M this year. During the period from 2010 to 2024 Nuwellis Other Liabilities annual values regression line had geometric mean of  314,652 and mean square error of 5.4 T. View All Fundamentals
 
Other Liabilities  
First Reported
2010-12-31
Previous Quarter
7.9 M
Current Value
8.3 M
Quarterly Volatility
3.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nuwellis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuwellis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 255.5 K, Interest Expense of 3.7 M or Selling General Administrative of 10.1 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.34. Nuwellis financial statements analysis is a perfect complement when working with Nuwellis Valuation or Volatility modules.
  
Check out the analysis of Nuwellis Correlation against competitors.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.

Latest Nuwellis' Other Liab Growth Pattern

Below is the plot of the Other Liab of Nuwellis over the last few years. It is Nuwellis' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuwellis' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Nuwellis Other Liab Regression Statistics

Arithmetic Mean1,652,221
Geometric Mean314,652
Coefficient Of Variation189.77
Mean Deviation2,413,686
Median126,000
Standard Deviation3,135,446
Sample Variance9.8T
Range8.2M
R-Value0.70
Mean Square Error5.4T
R-Squared0.49
Significance0
Slope493,011
Total Sum of Squares137.6T

Nuwellis Other Liab History

20248.3 M
20237.9 M
20226.9 M
2018179 K

About Nuwellis Financial Statements

Nuwellis stakeholders use historical fundamental indicators, such as Nuwellis' Other Liab, to determine how well the company is positioned to perform in the future. Although Nuwellis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nuwellis' assets and liabilities are reflected in the revenues and expenses on Nuwellis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nuwellis. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities7.9 M8.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Nuwellis is a strong investment it is important to analyze Nuwellis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuwellis' future performance. For an informed investment choice regarding Nuwellis Stock, refer to the following important reports:
Check out the analysis of Nuwellis Correlation against competitors.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuwellis. If investors know Nuwellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuwellis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(60.77)
Revenue Per Share
48.483
Quarterly Revenue Growth
0.057
Return On Assets
(0.79)
Return On Equity
(9.87)
The market value of Nuwellis is measured differently than its book value, which is the value of Nuwellis that is recorded on the company's balance sheet. Investors also form their own opinion of Nuwellis' value that differs from its market value or its book value, called intrinsic value, which is Nuwellis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuwellis' market value can be influenced by many factors that don't directly affect Nuwellis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuwellis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuwellis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuwellis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.